Trimetrexate in the treatment of recurrent or advanced leiomyosarcoma of the uterus: a phase II study of the Gynecologic Oncology Group

Trimetrexate in the treatment of recurrent or advanced leiomyosarcoma of the uterus: a phase II study of the Gynecologic Oncology Group

Item
http://www.wikidata.org/entity/Q28212040
Q28179513
sameAs
Comparative genomics analysis of Mycobacterium ulcerans for the identification of putative essential genes and therapeutic candidatesA Phase II evaluation of ixabepilone (IND #59699, NSC #710428) in the treatment of recurrent or persistent leiomyosarcoma of the uterus: an NRG Oncology/Gynecologic Oncology Group StudyFixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial.Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: a Gynecologic Oncology Group phase II studyLocally-advanced unresected uterine leiomyosarcoma with triple-modality treatment combining radiotherapy, chemotherapy and hyperthermia: A case report.Inhibition of uterine sarcoma cell growth through suppression of endogenous tyrosine kinase B signaling.Pharmacological treatment for uterine leiomyosarcomas.Optimal management of uterine leiomyosarcoma.Feasibility study of gemcitabine plus docetaxel in advanced or recurrent uterine leiomyosarcoma and undifferentiated endometrial sarcoma in Japan.
P2860

Trimetrexate in the treatment of recurrent or advanced leiomyosarcoma of the uterus: a phase II study of the Gynecologic Oncology Group

Item
http://www.wikidata.org/entity/Q28212040
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Trimetrexate in the treatment ...... the Gynecologic Oncology Group
@ast
Trimetrexate in the treatment ...... the Gynecologic Oncology Group
@en
Trimetrexate in the treatment ...... the Gynecologic Oncology Group
@nl
type
label
Trimetrexate in the treatment ...... the Gynecologic Oncology Group
@ast
Trimetrexate in the treatment ...... the Gynecologic Oncology Group
@en
Trimetrexate in the treatment ...... the Gynecologic Oncology Group
@nl
prefLabel
Trimetrexate in the treatment ...... the Gynecologic Oncology Group
@ast
Trimetrexate in the treatment ...... the Gynecologic Oncology Group
@en
Trimetrexate in the treatment ...... the Gynecologic Oncology Group
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Trimetrexate in the treatment ...... the Gynecologic Oncology Group
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698